Partners

https://www.erasmusmc.nl/  

https://www.icm.unicancer.fr/fr  

https://www.klinikum.uni-heidelberg.de/  

Health Innovation Ventures B.V. aims to revolutionise healthcare through several approaches. Specifically, two departments of Health Innovation V entures will be involved in the IMMUNOSABR project: OncoRadiomics department (HIV/OR): “Revolutionizing Precision Medicine with Quantitative Imaging [...]

Philogen (http://www.philogen.com/) was founded in 1996 with the mission to develop new bio- pharmaceuticals for the treatment of angiogenesis-related disorders, such as cancer, rheumatoid arthritis and endometriosis. The company has been a pioneer in the [...]

Radboud university medical center is a leading academic center for patient care, education and research, with the mission ‘to have a significant impact on healthcare’. Our activities help to improve healthcare and consequently the health [...]

OncoRay is an interdisciplinary research center established in 2005 and financed by the Technische Universität Dresden, the University Hospital Dresden and the Helmholtz-Zentrum Dresden- Rossendorf. OncoRay together with its sister institution HIRO Heidelberg has been [...]

University College London Cancer Institute and the University College Hospital form a leading UK Comprehensive Cancer Centre, combining basic cancer biology and translational research with delivering excellent cancer care. The research proposed within this application [...]

We are an academic tertiary care center treating 2500 new cancer patients per year (>45000 fractions). Our clinical and scientific expertise include a broad spectrum of modern cancer therapy including imaging and high-precision radiotherapy. Our [...]